Cargando…
Lipidomics for the Prediction of Progressive Liver Disease in Patients with Alcohol Use Disorder
Alcohol-related liver disease is a public health care burden globally. Only 10–20% of patients with alcohol use disorder have progressive liver disease. This study aimed to identify lipid biomarkers for the early identification of progressive alcohol-related liver disease, which is a key step for ea...
Autores principales: | Gao, Bei, Zeng, Suling, Maccioni, Luca, Shi, Xiaochun, Armando, Aaron, Quehenberger, Oswald, Zhang, Xinlian, Stärkel, Peter, Schnabl, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146183/ https://www.ncbi.nlm.nih.gov/pubmed/35629937 http://dx.doi.org/10.3390/metabo12050433 |
Ejemplares similares
-
Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease
por: Maccioni, Luca, et al.
Publicado: (2021) -
Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder
por: Hartmann, Phillipp, et al.
Publicado: (2021) -
Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans
por: Maccioni, Luca, et al.
Publicado: (2020) -
Integrative Analysis of Metabolome and Microbiome in Patients with Progressive Alcohol-Associated Liver Disease
por: Gao, Bei, et al.
Publicado: (2021) -
Toll-like receptor 2 activation in monocytes contributes to systemic inflammation and alcohol-associated liver disease in humans
por: Maccioni, Luca, et al.
Publicado: (2023)